About Oxford Outcomes
Oxford Outcomes, established in 1997, is a leading international health outcomes consultancy with offices in the UK (Oxford), Canada (Vancouver and Toronto) and the US (Bethesda, MD and Morristown, NJ).
The company provides a broad spectrum of specialist services in:
- patient reported outcomes research
- health economics
- epidemiology
- infectious disease research
- translation and linguistic validation
We also bring these disciplines together in service packages to support the drug development lifecycle through early stage development and investment, market access, reimbursement, regulatory approvals, peri-approval and marketing development process.
The company's consulting services are led by a strong group of consultants and opinion leaders from health economics and outcomes research including:
- Health economics: Dr Mark Sculpher, Dr Andrew Briggs, Dr Neil Hawkins, David Scott, John Schneider
- Patient reported outcomes: Diane Wild, Dr Andrew Lloyd, Kathy Beusterien
- Epidemiology: Dr Adrian Levy
- Management and administration: Paul Quarterman (Group Managing Director, UK Managing Director), Brian Harrigan (Chief Operating Officer, USA and Canada)
This senior team is supported by a strong group of senior and junior consultants that has grown over several years to blend research expertise with consultancy, problem-solving and communication skills.